This is a good sign that your treatment is working, even if some symptoms are still improving
In the AMPLITUDE-O post-hoc analysis, the HR for MACE was 0.70 (95% CI 0.371.30) with baseline SGLT2is and 0.74 (95% CI 0.580.94) without SGLT2is ( P -value for interaction 0.70), and the HR for HHF was 0.23 (95% CI 0.050.97) with SGLT2is and 0.70 (95% CI 0.421.17) without SGLT2is ( P -value for interaction 0.35) [47]
Ensure you are getting enough protein to support your body
Emerging clinical evidence lends support to this concept across different intervention timepoints: Prenatal/Perinatal Strategy: A randomized study involving 100 pregnant women at high risk for preterm delivery compared prophylactic administration of L-carnitine plus dexamethasone versus dexamethasone alone
Research Citations Brown, K., Nguyen, T., & Patel, R
The temporal association between starting a new medication and developing PMB does not establish causation, and the standard diagnostic pathway must be followed to exclude serious pathology